The board meeting for BioXcel Therapeutics Inc is scheduled for today, for the purpose of BioXcel Therapeutics Inc First Quarter Earnings Results for 2025See details
BioXcel Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of 47.6%, and profit growth estimate of -13.7% for FY25, based on top 4 analyst calls.